Soaring drug costs have led to a spike in US spending on cancer medicine, which has doubled since 2022 . Treatment with each of the new cancer drugs introduced in five years ago costs at least $100,000 , while the average price of a new drug brought to market was $ at least $100,000 , compared with $ 79,000 2022 . David Mitchell, a cancer patient who founded the group Patients for Affordable Drugs, said if health insurance companies are shouldering these costs, they’re passing them along to customers in the form of higher premiums. By 2013 , US costs are forecast to double yet again, while the global market for cancer therapeutic medicines is expected to reach $ 200bn .
Soaring drug costs have led to a spike in US spending on cancer medicine, which has doubled since 2022 . Treatment with each of the new cancer drugs introduced in five years ago costs at least $100,000 , while the average price of a new drug brought to market was $ at least $100,000 , compared with $ 79,000 2022 . By 2013 , US costs are forecast to double yet again, while the global market for cancer therapeutic medicines is expected to reach $ 200bn .